CTSO : Summary for CYTOSORBENTS COR - Yahoo Finance

U.S. Markets close in 2 hrs 16 mins

Cytosorbents Corporation (CTSO)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
5.55-0.05 (-0.89%)
As of 1:27PM EST. Market open.
People also watch
AEMDELTPADXSONCSIGXT
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close5.60
Open5.60
Bid5.55 x 4200
Ask5.60 x 400
Day's Range5.55 - 5.60
52 Week Range3.80 - 6.90
Volume10,671
Avg. Volume61,122
Market Cap141.35M
Beta0.96
PE Ratio (TTM)-14.76
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Accesswire15 days ago

    CytoSorbents to Present at the 2nd Annual Disruptive Growth & Healthcare Conference

    NEW YORK, NY / ACCESSWIRE / February 8, 2017 / CytoSorbents Corporation (NASDAQ: CTSO ), a critical care immunotherapy leader using blood purification to treat deadly inflammation in critically-ill and ...

  • PR Newswire16 days ago

    CytoSorbents to Present at the 19th Annual BIO CEO & Investor Conference

    MONMOUTH JUNCTION, N.J., Feb. 7, 2017 /PRNewswire/ -- CytoSorbents Corporation (CTSO), a critical care immunotherapy leader using blood purification to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announced that its Chief Executive Officer, Dr. Phillip Chan, MD, PhD, will present at the 19th Annual BIO CEO & Investor Conference next week in New York City.

  • PR Newswirelast month

    CytoSorbents Launches VetResQ™ for U.S. Veterinary Market

    MONMOUTH JUNCTION, N.J., Jan. 20, 2017 /PRNewswire/ --  CytoSorbents Corporation (NASDAQ: CTSO), a critical care immunotherapy leader using blood purification to treat deadly inflammation in critically-ill ...